Vein911® Vein Treatment Centers CEO Appointed to Advisory Board of Blockchain Based Healthcare Company

Vein911® Vein Treatment Centers announced that Medical Director and CEO, Christopher Pittman, M.D., has been appointed to the advisory board of Appley Health.

Their patent-pending platform will eliminate multiple layers of intermediaries and lower the cost of self-funded employer health plans.”

— Dr. Chris Pittman, CEO of Vein911® and Health Performance Specialists

TAMPA, FL, UNITED STATES, July 24, 2018 /EINPresswire.com/ — Vein911® Vein Treatment Centers announced today that Medical Director and CEO, Christopher Pittman, M.D., has been appointed to the advisory board of Appley Health. Appley Health uses cutting edge technology to markedly reduce the cost of self-funded employer health plans. They leverage blockchain technology allowing self-funded employers to directly contract, interact, and transact in a totally transparent, immutable, and efficient manner.

Christopher Pittman, M.D. has over 25 years of medical practice management experience and is a nationally recognized expert and thought leader on health care policy, medical economics, medical informatics, and health information technology. He serves as Medical Director and CEO of Vein911® Vein Treatment Centers and CEO of Health Performance Specialists. In addition to his professional duties, Dr. Pittman serves on the Board of Directors of the American College of Phlebology and as the College’s Delegate to the American Medical Association. He is Immediate Past President of the Florida Medical Association Political Action Committee (FMA PAC), Past President of the Hillsborough County Medical Association, and has served on the Board of Governors of the Florida Medical Association.

“Appley Health is positioned to disrupt health care by using blockchain technology,” said Dr. Chris Pittman, CEO of Vein911® and Health Performance Specialists. “Their patent-pending platform will eliminate multiple layers of intermediaries and lower the cost of self-funded employer health plans.”

About Vein911® Vein Treatment Centers
Vein911® is a leading provider of both medical and cosmetic vein care including varicose veins, ankle swelling, restless legs, night cramps, venous leg ulcers, and cosmetically disturbing veins of the hands, face and legs. Our world-class vein treatment centers offer state of the art technology within elegant and comfortable surroundings and a family atmosphere. Our non-surgical medical procedures include VenaCure EVLT Endovenous Laser Treatment, Venefit procedure using ClosureFast Endovenous Radiofrequency Ablation (RFA) and Ultrasound-Guided Foam Sclerotherapy which is the future of vein care available today at Vein911®. Our cosmetic procedures include Visual Sclerotherapy, the gold standard treatment for spider veins, and VeinGogh, an immediately effective treatment for facial veins. Vein911® is the varicose vein and spider vein treatment center of choice for physicians and their patients who are experiencing vein disease. Our vein treatment centers are conveniently located throughout the Tampa Bay area and are led by board-certified vein care specialist physicians. Learn more at Vein911.com.

About Appley Health
Appley Health was founded by a veteran doctor and is focused on empowering employers and employees to lower cost and have more control over their healthcare by freeing them from the cost and headache associated with large intermediaries. Through the use of blockchain technology, Appley is creating a transparent, cost-effective platform that is more secure, faster and just plain better than any other option. To learn more about how Appley Health can help self-funded employers slice real cost out of healthcare, visit AppleyHealth.com.

Doug Pace
Vein911 Vein Treatment Centers
855-834-6911
email us here


Source: EIN Presswire

Marketing New and Improved Products Will Drive The Major Orthopedic Joint Replacement Implants Market

LONDON, GREATER LONDON, UK, July 24, 2018 /EINPresswire.com/ — The Business Research Company's new report, Major Orthopedic Joint Replacement Implants Global Market Strategies and Opportunities to 2022, estimates that major orthopedic joint replacement implants market will grow at a compound annual growth rate (CAGR) of 3.8%.

This market growth is being achieved through the implementation of marketing strategies that focus on new product development, improving existing products, and increased investments in emerging countries.

The established companies in the market are continually investing in research and development. B. Braun Melsungen, for instance, has spent €262.4 million for research and development of new products. Zimmer Biomet invested 5% of its total sales in 2017 in R&D to develop innovative products. Generic companies are increasingly gaining traction through their product development strategies, by making copies of legacy implants with proven designs and biomaterials and further offering them at lower prices compared to branded implants, thereby posing a threat for major orthopedic device manufacturers such as Stryker, Johnson & Johnson, Zimmer, Smith & Nephew and Medtronic Spine. This has led to increased interest in launching new products at competitive prices. Johnson & Johnson has adopted a similar yet different strategy of offering premium products at premium prices. On the other hand, we have Stryker and Medtronic that offer different product portfolios at different pricing.

Download a sample of the report at https://www.thebusinessresearchcompany.com/sample.aspx?id=801&type=smp.

A strategy being adopted by companies for product improvement involves the use of robotic technologies to increase efficiency and reduce the failure rate of knee surgery. Robots help in reducing the time required for surgical procedures and offer better results by eliminating the risks of complications. Companies such Stryker and Smith and Nephew believe that robots give them an edge in the major orthopedic replacement implants market. For instance, in 2017, Stryker Corporation launched the MAKO robot which is enabled to perform total knee replacement in the US. In 2016, Smith and Nephew launched its Navio surgical robot to perform knee replacement surgery in the US. The robot, which initially performed partial knee surgery, recently conducted its first full knee replacement surgery in New York and was given an approval by the US Food and Drug Administration (FDA).

The use of 3D printing technology in implants is another effort aimed at providing reliable and customized surgery for patients. 3D printing reduces the risk of a wrong fit by producing components used in the surgery through using the patient’s X-rays images or CT scans which.

Major orthopedic implant manufacturing companies are investing in emerging countries such as India, China and Brazil which constitute around 41% of the total world population. Smith & Nephew, for instance, is investing in established markets, accelerating development in emerging markets, simplifying and improving their operation model, and supplementing organic growth through acquisition.

TBRC’s primary interviews also reveal that marketing strategies aimed towards young and more active patients will be a driver of the major orthopedic joint replacement implants market. As part of their marketing strategies, companies may reach out to government hospitals, clinics, and private hospitals, and speak to surgeons to promote their products for good sales numbers. Zimmer Biomet, which was the largest competitor in the market in 2017, offers solutions that support orthopedic surgeons and clinicians in restoring mobility and treating arthritis and traumatic injuries.

Where To Learn More
Read the Major Orthopedic Implants Replacement Global Market Opportunities and Strategies to 2022 report from The Business Research Company for information on the following:

Markets Covered: Major orthopedic joint replacement implants market
Major Orthopedic Implants Replacement Market Companies Covered: Zimmer Biomet, Depuy Syntes, Stryker, Smith & Nephew, Aesculap, Exactech, DJO Global, Corin Orthopedics
Regions: North America, Asia Pacific, Western Europe, South America, Eastern Europe, Middle East, Africa.
Countries: USA, China, UK, Japan, France, Germany, Australia, India, Spain, Russia, Italy, Brazil
Time Series: Five years historic (2013-17) and forecast (2017-21).
Data Segmentations: Major orthopedic joint replacement implants market historic and forecast size and growth rates for the world, 7 regions and 12 countries, major orthopedic implants replacement market segmentation by type of joint (knee replacement implant, hip replacement implant), by facility (in-patient care, ambulatory care), by type of fixation(cementless, cemented, hybrid), by type of material (ceramics, metals, polymers), and by type of material combination (metal on polymer, ceramic on polymer, ceramic on ceramic, metal on metal, ceramic on metal) market shares, historic and forecast size and growth rates for the world, 7 regions and 12 countries, global competitor sales and market shares.
Other Data: Per capita average major orthopedic joint replacement implants market expenditure, global and by country, major orthopedic joint replacement implants market size as a percentage of GDP, global and by country; major orthopedic joint replacement implants market customer information, global number of major orthopedic joint replacement implants market enterprises for 2017, average major orthopedic joint replacement implants market revenue per enterprise for 2017, global number of employees in the major orthopedic joint replacement implants market for 2017, and average revenues per employee in the medical equipment industry for 2017- by country
Other Information: Drivers and restraints of the major orthopedic joint replacement implants market, PESTEL analysis, company profiles including products, strategy and financial performance for 5 major orthopedic joint replacement implants market companies, major orthopedic joint replacement implants market trends and strategies, major orthopedic joint replacement implants market key mergers and acquisitions.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes. Sources include primary as well as extensive secondary research.
Number of figures in the report: 141
Number of tables in the report: 153

Download Complete Table of Contents at https://www.thebusinessresearchcompany.com/sample.aspx?id=801&type=toc

Interested to know more? Here is a list of reports similar to “Major Orthopedic Joint Replacement Implants Global Market Strategies and Opportunities to 2022”:
Medical Equipment Global Market Report 2018
Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021
Healthcare Services Global Market Report 2018

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here


Source: EIN Presswire

Myra Lovvorn of SUPPOSE to be Featured on CUTV News Radio

RICHMOND, VIRGINIA, UNITED STATES, July 24, 2018 /EINPresswire.com/ — In her final broadcast, Oprah Winfrey revealed she had interviewed 30,000 people over the life of her TV show, from the poorest of the poor to the richest of the rich, and every one of them had problems with self-worth at some point in their lives. Indeed, self-esteem, a person's overall sense of self-worth or personal value, is essential for a positive attitude toward life and success.

Some people never develop self-esteem because they believe the world is happening to them; they never suspect that they might have something to do with it. As a holistic nurse practitioner specializing in hospice, Myra Lovvorn saw firsthand how low self-esteem can lead a person toward a premature end.

“Working at the bedside of people dying, listening to their stories I remember thinking they wouldn't be dying if they had only made some different choices,” says Myra. “There was just something emotional in what they were saying that led me to realize that if someone had stepped in and helped them back then, they wouldn’t be in that hospice bed.”

Today, Myra is the founder of SUPPOSE, where she offers her clients a path to change their subconscious beliefs and boost their self-esteem.

“SUPPOSE stands for the “Subconscious Understands the Powerful Perception of Self Esteem,” says Myra. “Our whole life is about figuring out who we are and what we are, and we gauge it by comparing ourselves to other people. I believe you have everything you need at your disposal, you just need to learn to access it and unlock it.”

To improve our self-esteem, we need to change our existing beliefs. In addition to her skills as a holistic nurse practitioner, Myra is an instructor and facilitator of PSYCH-K®, a unique modality that helps us change the subconscious beliefs that perpetuate our old habits of thinking and behavior. She has achieved remarkable results.

“What I love about PSYCH-K is that it asks permission of our higher self and our subconscious mind.”

CUTV News Radio will feature Myra Lovvorn in an interview with Jim Masters on July 25th at 11am EDT.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Myra Lovvorn, visit https://www.supposellc.com

The Heart of Hospice: Core Competencies for Reclaiming the Mystery is available on Amazon

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Vantage Agora Hits a Hole-in-One With Custom Software for Golf Insurance Expert

OX Zion is a customizable software system that handles everything, and can be developed quickly to help your company hit a hole-in-one!

In just one month, Vantage Agora launched a custom software solution for Stellar Hole-in-One, making them eagles for quick prize insurance quotes.

OX Zion is designed to handle many different industries, and the scalability of our product enabled us to quickly build Stellar Hole-in-One’s software. We got the request in April and launched in May.”

— Arvind Gopalakrishnan, VP of Technical Sales, Vantage Agora

CLEVELAND, OHIO, UNITED STATES, July 24, 2018 /EINPresswire.com/ — The team at Vantage Agora has once again exceeded expectations by building a custom software solution for Stellar Hole-in-One – in just one month. Using their expertise in Operational Excellence, Vantage Agora optimized OX Zion, their Business Operating System (BOS), to meet the specific requirements of this golf prize insurance provider.

Although OX Zion is well-equipped to serve nearly any business, Stellar Hole-in-One needed a software that would assist with insurance for clients who want to coordinate prize-centered golf events, like hole-in-one competitions. Rather than covering the cost of the prizes themselves, Stellar Hole-in-One’s customers pay a nominal contract fee and let the insurance company handle the prize amount when a golfer makes a hole-in-one. The software Stellar Hole-in-One required had unique functionalities, including the ability to provide quotes, assess risk, create and manage policies.

Considering the seasonal nature of golf, a quick and seamless implementation was a must. This is where OX Zion came in. Since no existing product would accommodate all aspects of Stellar Hole-in-One’s business needs, Vantage Agora built a custom solution with lightning speed.

Arvind Gopalakrishnan, VP of Technical Sales for Vantage Agora, stated, “OX Zion is designed to handle many different industries, and the scalability of our product enabled us to quickly build Stellar Hole-in-One’s software. We got the request in April and launched in May.”

The call center CSR software is user-friendly and built to streamline the process by automatically populating information across multiple screens (to eliminate unnecessary clicks), printing contract forms and endorsements, housing data for quotes, and more. And, since OX Zion is cloud-based, it can be accessed from anywhere, making it ideal for busy entrepreneurs.

“Time was of the essence in this project to launch in time for the golf season. The Vantage Agora team was amazing in both their ability to quickly grasp our business logic and their ability to apply that logic for a successful launch on time. We are very grateful for their effort,” Doug Burkert stated.

If your business needs a software system that handles everything – and needs it developed quickly – Vantage Agora can create a custom solution using OX Zion to help your company hit a hole-in-one!
 
ABOUT VANTAGE AGORA, INC.
Vantage Agora is a Beachwood, Ohio-based team with expertise in operations, technology, Six Sigma, lean management, business process re-engineering (BPR) and business process management (BPM). They focus on helping clients boost profits by improving operational control and enhancing data visibility. Vantage Agora also offers OX Zion, a dynamic Business Operating System software that launched in 2013. For information, news and events, visit www.vantageagora.com.

ABOUT STELLAR HOLE-IN-ONE
Stellar Hole-in-One is a Dallas-based hole-in-one prize insurance company that was founded by Doug Burkert, an expert with 25 years in golf prize coverage. He and his team have experience in assisting with over 250,000 golf events worldwide and provide more sponsor visibility, most complete coverage with favorable rules that make the hole-in-one competitions better. Their coverage is through Amalgamated Casualty Insurance Company (rated as Excellent by A.M. Best). For more information on Stellar Hole-in-One, visit www.stellarholeinone.com.

Allison Shumaker
Vantage Agora
888.246.7211 x 107
email us here


Source: EIN Presswire

Child and Adolescent Psychiatrist Jack Westman to be Featured on CUTV News Radio

MADISON, WISCONSIN, UNITED STATES, July 24, 2018 /EINPresswire.com/ — Child abuse is shockingly widespread and has resulted in a catastrophic impact on our society as a whole. Is it possible to prevent actual abuse from occurring if we take the right steps to halting this horrendous exploitation directed towards our innocent young citizens?

Jack Westman is an exceptional child and adolescent psychiatrist for over 60 plus years and the esteemed author of fourteen books including “Parent Power: The Key to American Prosperity,” “The Cancer Solution: Taking Charge of Your Life with Cancer” and “Dealing with Child Abuse and Neglect as Public Health Problems: Prevention and the Role of Juvenile Ageism.”

“My specialty is working with families in collaboration with educational and political systems and work diligently with children with behavioral problems,” says Jack. “I am not a doctor who prescribes medication. I work holistically with children. I am actively in pursuit of developing public policies to assist families so that every child has the prospect of making succeeding in the life.”

Jack was inspired by Sigmund Freud’s famed theory of the ID, Ego and Super Ego, how we all have impulses to do unscrupulous and virtuous deeds and how we possess skills we can apply in our lives that will lead us to be as productive as possible. Understanding human behavior is what set Jack’s course in life to gain a profound understanding of children’s vital roles in society.

“We can take major steps towards foiling child abuse,” says Jack. “By being actively influential in children’s lives we guide them into leadership roles.”

Jack’s most recent book has been on the atrocities and damaging effects of child abuse and neglect. He intensely reasons that society does nothing to prevent child abuse and neglect but only intervenes when children have been damaged years after abuse has taken place.

“I’m calling attention to juvenile ageism defined as prejudice based on young age,” says Dr. Westman. “Society imagines ageism as bias and prejudgment towards the elderly when actually the most helpless people subjected to prejudice are newborn babies and children. This means children are woefully viewed as objects and personal possessions of their parents which is egregious and destructive.”

According to Jack, this unrecognized prejudice is more powerful than racism or sexism and, if you look at it objectively it has appalling ill effects in society where children can grow up to become abusers themselves, suffer mental or physical effects or become dysfunctional members of society.

“Teachers and child care workers are grossly underpaid when their salaries should commensurate with the important work they contribute.” says Jack. “Our society does not fully recognize young people and the value of appreciating their status in our world. It’s absolutely critical that adults speak out in their defense and that’s what I’ am doing.”

CUTV news will feature Jack C. Westman in an interview with Doug Llewelyn on Wednesday July 25thh at 12 noon EST.

Listen to the show on BlogTalkRadio.

If you have any questions for our guest, please call (347) 996-3389.

For more information on our guest please visit www.jackwestman.com

Author: Beatrice Maria Centeno

Lou Ceparano
CUTV News
(631) 850-3314
email us here


Source: EIN Presswire

Abyde and PECAA Sign Partnership Agreement

The partnership will allow PECAA members access to Abyde’s educational HIPAA webinars as well as exclusive discounts for Abyde’s best-in-class HIPAA solution.

Our partnership with Abyde provides Members a way to address the necessity of being HIPAA compliant in an efficient and effective manner”

— PECAA Member Business Advisor and Billing & Coding Expert, Teri Thurston

TAMPA, FL, UNITED STATES, July 24, 2018 /EINPresswire.com/ — Abyde, the leading HIPAA compliance management software for medical practices, and PECAA, a nationwide Doctor Alliance Group for Independent Doctors, announced today a partnership committed to simplifying HIPAA difficulties for PECAA members.

“Tackling HIPAA Compliance without outside help can be complicated and seem overwhelming. Our partnership with Abyde provides Members a way to address the necessity of being HIPAA compliant in an efficient and effective manner,” says PECAA Member Business Advisor and Billing & Coding Expert, Teri Thurston. “Abyde alleviates the confusion and strain associated with compliance, enabling Members to focus on their true top priorities – their patients and their practice.”

The partnership will allow PECAA members exclusive access to Abyde’s educational HIPAA webinars as well as exclusive discounts for Abyde’s best-in-class HIPAA solution.

“We are elated PECAA leadership has chosen Abyde to be their trusted HIPAA resource,” said Matt DiBlasi, President of Abyde. “This is a responsibility we take very seriously. We are ecstatic for the opportunity to work closely with more of PECAA’s valued members going forward.”

Launched in January of 2017, Abyde is a revolutionary, cloud-based software solution that enables eye care professionals to easily attain and sustain internal HIPAA compliance programs by walking them through the Risk Analysis, ongoing compliance, policy, procedure, and HIPAA training requirements. Abyde’s automated Risk Analysis also meets Meaningful Use, MACRA, and MIPS Protecting Electronic Health Information core measures.

About Abyde:
Abyde (Tampa, FL) is a technology company dedicated to revolutionizing HIPAA compliance for medical professionals. Launched in January 2017, Abyde was formed with the idea there could exist an easier, more cost-effective way for healthcare providers to comply with government-mandated HIPAA regulations. For more information on Abyde visit www.abyde.com or call (800) 594-0883.

About PECAA:
PECAA is one of the nation’s leading Doctor Alliance Groups serving 2,700 Independent Eye Care Professionals throughout the United States. PECAA’s mission is to help propel member practices forward through best-in-class business resources. PECAA offers its members customized tools, progressive tactics, business advice, marketing support, education, vendor relationships and peer-to-peer camaraderie to help members attract more patients, improve their bottom line and build a flourishing business.

Jake Dewberry
Abyde
800-594-0883
email us here


Source: EIN Presswire

Imprivata extends multi-factor authentication to handheld devices with the launch of Mobile Device Access solution

New solution gives clinicians fast, secure and auditable access to shared mobile devices and applications with just the tap of a badge

Imprivata Mobile Device Access enables healthcare organisations to unlock the full potential of their investment in clinical mobile devices and applications.”

— Adam Bangle, VP International Sales, Imprivata

LONDON, UK, July 24, 2018 /EINPresswire.com/ — Imprivata® the healthcare IT security company, today introduced Imprivata Mobile Device Access™ which enables fast, secure access to clinical mobile devices and applications. The new solution extends the capabilities of Imprivata OneSign® and the Imprivata identity and access management platform enabling fast, secure access to shared mobile devices and applications with the tap of a proximity badge. As a result, organisations can unlock the full potential of these devices and applications ensuring a fast, efficient workflow for clinicians and care givers whilst maintaining security and auditability.

Delivering 21st century healthcare while safe-guarding sensitive patient records with ever-decreasing budgets is a real challenge for healthcare professionals. Hospitals are increasingly turning to mobile technology to automate and streamline time consuming manual processes. However, the workflows to access shared mobile devices and applications can be frustratingly cumbersome and become a barrier to usage. If access is frustrating and challenging, staff could seek insecure workarounds which then creates risk in information governance, potential GDPR data breaches, and lead to inaccurate data being recorded for auditing.

Imprivata Mobile Device Access supports the mobility of clinical staff and brings technology to the bedside by improving usability of shared clinical mobile devices and applications. The solution removes the need for repetitive manual logins and complex passwords typed on small mobile keyboards, providing fast, secure, access and replacing the need for password entry with the simple tap of a badge, then single sign-on into applications. It Increases the security of mobile devices and applications by requiring strong authentication to access the device. As a result, organisations can unlock the full potential of shared devices and applications by ensuring a fast, efficient workflow for clinicians while maintaining (and improving) security and auditability.

Imprivata MDA integrates seamlessly with Imprivata OneSign, healthcare’s leading enterprise SSO and virtual desktop access platform, leveraging the same core infrastructure. This allows organisations to set authentication policies for all workflows from a single platform which reduces TCO and streamlines reporting.

Adam Bangle, VP International Sales at Imprivata explains; “The healthcare ecosystem is evolving, and mobile devices are increasingly becoming prevalent in patient care. Imprivata Mobile Device Access enables healthcare organisations to unlock the full potential of their investment in clinical mobile devices and applications. The solution increases usability and removes barriers to adoption whilst improving security by requiring strong authentication to access mobile devices. The result is happier users embracing the technology and organisations realising full utilisation of their investment in elevating patient care.”

Andreina West
PR Artistry
44 1491 845553
email us here


Source: EIN Presswire

Protein Dynamic Solutions appoints Selena Larkin as Chief Commercial Officer

Dr. Selena Larkin – CCO of Protein Dynamic Solutions

PDS, developer of breakthrough technologies for characterization of therapeutic proteins, announces appointment of Dr. Selena Larkin to its leadership team.

……the PDS team come directly from the biopharma space and have developed a solution to a very real problem. They have lived in those peoples’ shoes and lab coats!”

— Dr. Selena Larkin

WAKEFIELD, MA, USA, July 24, 2018 /EINPresswire.com/ — Wakefield, MA – July 24, 2018 – Protein Dynamic Solutions LLC (PDS), developer of breakthrough technologies for biopharmaceutical characterization of therapeutic proteins, announces the appointment of Dr. Selena Larkin to its leadership team.

PDS’ flagship product ProteinMentor TM is a high-throughput drug developability and comparability assessment tool which uses a unique combination of laser-microscopy and molecular spectrometry to determine aggregate size as well as the identity, extent, region and mechanism of protein aggregation – thus allowing for improved clonal selection, formulation and re-engineering. An array-based format, 24 samples can be assessed simultaneously for direct comparison of clones, formulations or other factors over a range of stressor conditions such as ramped temperature or agitation.

“We are delighted to welcome Selena to the PDS team”, said Dr. Belinda Pastrana, CEO. “Her experience promoting innovative technologies across her global biopharmaceutical network and her understanding of, and enthusiasm for, protein chemistry will further speed adoption of PDS’ enabling platforms”.

In addition to critical quality attribute (CQA) assessment, ProteinMentor also enables comparability testing following process changes and has been demonstrated for biosimilarity testing, including use by innovator pharma companies to extend their patent protection.

“I am very excited to join this growing organization and drive continued market development for a truly enabling technology across the biopharmaceutical value chain”, Dr. Larkin said. “The platform is elegant in the simplicity of the workflow and user experience, with no confounding fluidic streams or labels, and also in the richness of actionable data generated from each and every experiment.”

Dr. Pastrana’s team is comprised of scientific and regulatory experts from the biopharmaceutical and bioprocessing industry including such companies as Eli Lilly, Abbvie and Johnson & Johnson. PDS’ platforms were specifically developed to address the need to study many sample permutations in the one experiment over a range of stress conditions at concentrations and sample sizes pertinent to the biopharma industry. The ProteinMentor platform is a turn-key, low maintenance system, with real-time data acquisition and enhanced signal to noise that allows users to actually “see” particulates within the sub-visible range and zoom in to evaluate each for molecular mechanism and structural change. This simple, multi-parameter analysis makes PDS data actionable across the drug development pipeline from candidate selection through excipient optimization and final delivery / quality testing.

“An exciting aspect of working with the PDS team is that they come directly from the biopharma space and have developed a solution to a very real problem.” Selena said. “They really appreciate their clients’ workflow and needs because they have lived in those peoples’ shoes and lab coats!”

Selena has a strong track record of driving business growth for small and large enterprises alike. Having kick-started the commercial efforts for a number of emerging technologies, she most recently served as Senior Director of Business Development at SCIEX, a Danaher company. Selena has held senior leadership roles at Agilent Technologies, including supporting the post-acquisition integration of BIOCIUS Life Sciences, where she was a founder and led the commercialization of RapidFire technology. Selena holds a Ph.D. in Medicine, majoring in protein chemistry, from the University of Melbourne, Australia and an M.B.A. in International Business from the University of Maryland.

About Protein Dynamic Solutions (PDS):
Headquartered in Wakefield, MA, and founded in the US bioprocessing hub of Puerto Rico, PDS develops breakthrough tools for bioanalysis of therapeutic candidates. Founder, Belinda Pastrana, is a renowned expert in protein conformation, having lectured over the world and trained a generation of analytical and physical chemists to work in the biologics industry. Her entire PDS team, including Board members and advisors, are veterans of biopharma and the life sciences with a strong track record for realization of cutting-edge technologies.
PDS’ flagship product is a high-throughput developability and comparability assessment tool – ProteinMentorTM – which utilizes a unique combination of microscopy and molecular spectroscopy to provide array-based visualization and analysis of protein drug formulations.

Selena Larkin
Protein Dynamic Solutions, LLC
+1 (978) 594-6955
email us here


Source: EIN Presswire

Vigilant Software’s game-changing update to its data protection platform

ELY, CAMBRIDGESHIRE, UNITED KINGDOM, July 24, 2018 /EINPresswire.com/ — Ely, United Kingdom, 24 July 2018 – Cyber security expert Vigilant Software has updated its CyberComply platform to make it easier than ever for organisations to track their personal data.

Organisations of any size can now use CyberComply’s Consultancy Access feature, enabling consultants or internal compliance managers to be added to multiple organisation or divisional accounts using just one set of login details. This makes the data management process more collaborative than ever before.

With data breaches on the rise, and the ICO (Information Commissioner’s Office) handing out major fines to several organisations, including Facebook, the importance of how organisations manage their data has never been more important. Vigilant Software’s Data Flow Mapping Tool, a module in their CyberComply platform, makes it easy for organisations to create data flow maps that help meet the GDPR Article 30 compliance requirements and can be reviewed, revised and updated when needed. Organisations can take advantage of Vigilant Software’s July launch promotion: purchase the Data Flow Mapping Tool before the end of July to get an 18-month licence for it.

Gemma Platt, managing executive of Vigilant Software, said: “The way in which organisations handle public data is becoming more important. At Vigilant Software, we believe that the Data Flow Mapping Tool is the ideal solution for many organisations, making it much easier for them to map their business processes. The ICO’s recent £500,000 fine for Facebook – a record amount – should be a warning to all: investing in compliance will cost organisations significantly less than any fine or reputational damage.”

A key part of this CyberComply update is that customer roles have been revised, so that more options are now available. These include:

Organisation admin;

Contributor;

Read only;

Revoked; and

Consultancy Access – How It Works.

For more information on CyberComply, the Data Flow Mapping Tool and Compliance Manager, please call our dedicated advisor on +44 (0)333 700 1 700 or click here.

Liam Papworth
IT Governance
+ 44 3338007000
email us here


Source: EIN Presswire

New York Mesothelioma Victims Center Now Urges a Skilled Trades Worker with Mesothelioma Anywhere In New York to Take Their Compensation Seriously and to Call About Why Hiring the Most Skilled Lawyers Is Vital

Call the New York Mesothelioma Victims Center at 800-714-0303 so they can make certain the victim of mesothelioma has direct access to the nation's most qualified mesothelioma attorneys on the spot.”

— New York Mesothelioma Victims Center

NEW YORK, NEW YORK, USA, July 24, 2018 /EINPresswire.com/ — According to the New York Mesothelioma Victims Center, "The most heartbreaking call we receive is from a grieving family who received a couple hundred thousand dollars in total mesothelioma compensation for their loved one in New York, when the claim could have been worth substantially more. Because the family hired a local car accident attorney, as opposed to one of the nation's most capable mesothelioma attorneys, there is nothing we can do to get them the settlement they deserved.

"We work weekdays, nights and weekends to provide people who have been diagnosed with mesothelioma in New York with the essential tools they need to have a successful mesothelioma compensation claim-including direct access to some of the nation's most skilled fulltime mesothelioma attorneys as we would like to discuss anytime at 800-714-0303. We specialize in assisting skilled trades workers and Navy Veterans and the New York City based mesothelioma lawyers we suggest are second to none." http://NewYork.MesotheliomaVictimsCenter.Com

The New York Mesothelioma Victims Center is urging recently diagnosed person with mesothelioma anywhere in New York who was exposed to asbestos as a skilled trades worker or Navy Veteran to call them at 800-714-0303 so they can make certain the victim of mesothelioma has direct access to the nation's most qualified mesothelioma attorneys on the spot. The group does not want one single person with mesothelioma in New York to get shortchanged or overcharged because they hired the wrong lawyers or law firm. http://NewYork.MesotheliomaVictimsCenter.Com

The New York Mesothelioma Victims Center specializes in assisting people nationwide with finding the most qualified attorneys if they were exposed to asbestos while working as a:

* Construction worker
* Electrician
* Plumber
* Welder
* Insulator
* Roofer
* Pipefitter
* Concrete specialist
* US Navy Sailor
* Shipyard
* Factory

The New York Mesothelioma Victims Center is especially focused on assisting former factory workers with mesothelioma in upstate New York-including the following communities: Buffalo, Amsterdam, Schenectady, Binghamton, Rochester, Syracuse, Watertown, Utica, Rome, or Poughkeepsie.

For the best possible mesothelioma treatment options in New York the New York Mesothelioma Victims Center strongly recommends the following three heath care facilities with the offer to help a diagnosed victim, or their family get to the right physicians at each hospital:
* New York City’s Memorial Sloan Kettering Cancer Clinic: http://www.mskcc.org/
* New York City’s Columbia Presbyterian Hospital: http://hiccc.columbia.edu/
* New York City’s Mount Sinai Hospital:
http://www.mountsinai.org/lung-cancer/about-lung-cancer/about-mesothelioma/

The New York Mesothelioma Victims Center specializes in financial compensation for diagnosed victims of mesothelioma. High-risk work groups for exposure to asbestos in New York include US Navy Veterans, power plant workers, maritime workers, shipyard workers, manufacturing, or industrial workers, plumbers, welders, electricians, auto mechanics, machinists, miners, railroad workers or construction workers. Typically, the exposure to asbestos occurred in the 1950’s, 1960’s, 1970’s, or 1980’s. Navy Veterans make up about one third of all people diagnosed with mesothelioma in the United States each year.

The states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon. However, based on the calls the Mesothelioma Victims Center receives a diagnosed victim of mesothelioma could live in any state including New York. http://NewYork.MesotheliomaVictimsCenter.Com

For more information about mesothelioma please refer to the National Institutes of Health’s web site related to this rare form of cancer: https://www.cancer.gov/types/mesothelioma

Michael Thomas
New York Mesothelioma Victims Center
800-714-0303
email us here


Source: EIN Presswire